Delivery Order SPE2DB20D3101-SPE2DB21FK4Y0

Award Date 9/10/21
Potential Completion Date 9/13/21
Potential Value $2.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,093.12 firm-fixed-price Delivery Order covers the supply of Methylergonovine 0.2 mg/mL injections to support military and government healthcare programs. The contract has a period of performance through February 5, 2024 and was not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999...
This federal contract award is between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,358.52, is for the delivery of methylergonovine 0.2 mg tablets to support military and government healthcare needs. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at...
The federal contract award is for the delivery of the pharmaceutical product Methylergonovine 0.2 mg/ml, valued at $2,874.65. The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop...
This federal contract award, SPE2DB20D1109|SPE2DB23FP51C, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,616.95 firm-fixed-price delivery order is for the pharmaceutical product Methylergonovine 0.2 mg/ml, with a completion date of July 13, 2023. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. The...
This federal contract award, with ID SPE2DB22D3016|SPE2DB24FAZP7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,459.40 firm-fixed-price delivery order is for the supply of 4565020812 - Methylergonovine 0.2 mg/ml vials. Amerisourcebergen is a major pharmaceutical distribution company that has received numerous federal contract awards to provide a wide range of medications, medical devices, and supplies to government agencies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,586.57 Delivery Order contract is for pharmaceutical and medical supply products to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $2,341.43, is a delivery order for pharmaceutical and medical supplies to support military healthcare programs. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $213,554.22 firm-fixed-price delivery order contract is for the provision of pharmaceutical products and medical supplies to support military and veterans' healthcare programs. It has an ultimate completion date of May 22, 2023. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award, issued by the Defense Logistics Agency (DLA), was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,531.47 firm-fixed-price delivery order is for pharmaceutical and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and medical devices. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,113.33 Firm Fixed Price Delivery Order contract is for the provision of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB21FK4Y0
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,423.14 firm fixed price delivery order is for the pharmaceutical product Methylergonovine 0.2 mg/mL and does not have a set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities and veterans' healthcare programs globally.

In addition to the DLA contract, Amerisourcebergen Drug Corp also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 10:59 AM